Status:
COMPLETED
Investigational Dementia Treatment Study
Lead Sponsor:
University of Manitoba
Collaborating Sponsors:
Riverview Health Centre Foundation
Charis Senior Residences LP. DBA Aster Gardens
Conditions:
Dementia, Mild
Eligibility:
All Genders
50-95 years
Phase:
NA
Brief Summary
This research investigates the effect of active versus sham tACS paired with cognitive exercises in a regimen protocol of weeks, everyday. The study design is a one-time crossing over design in which ...
Detailed Description
This research will investigate the effect of applying transcranial alternating current stimulation (tACS) when paired with cognitive exercises on older adults in a placebo-controlled double-blind stud...
Eligibility Criteria
Inclusion
- ability to read, write and speak English fluently
Exclusion
- Being diagnosed with Parkinson's, Parkinsonian dementia, Huntington disease, speech significant aphasia and intellectual disability, major depression/anxiety, bipolar disorder, schizophrenia or any other major mood disorder
- Having a History of epileptic seizures or epilepsy
- Inability to adequately communicate in English
- Impaired vision or hearing severe enough to impair performance in cognitive tests
- Current substance abuse disorder
- Currently participating in another therapeutic study for dementia
- Plan to change the medication during this study's period
Key Trial Info
Start Date :
January 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 6 2024
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT05203523
Start Date
January 24 2022
End Date
December 6 2024
Last Update
March 13 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Aster Gardens
Edmonton, Alberta, Canada
2
Riverview Health Centre
Winnipeg, Manitoba, Canada, R3L 2P4